N-terminal B-type natriuretic peptide (NT-proBNP) is associated with disease severity in multiple myeloma
European Journal of Clinical Investigation Feb 14, 2018
Pavo N, et al. - Researchers examined whether N-terminal B-type natriuretic peptide (NT-proBNP) levels were associated with disease severity in multiple myeloma (MM). They also evaluated the natural course of NT-proBNP levels throughout disease progression. Among patients with MM, elevated levels of the cardiovascular marker NT-proBNP were correlated with disease severity.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty -
Paid Market Research Surveys -
Case discussions, News & Journals' summaries
